<DOC>
	<DOCNO>NCT00155194</DOCNO>
	<brief_summary>Null hypothesis study : Biliary atresia patient cholestatic jaundice systemic immunity defect .</brief_summary>
	<brief_title>Evaluation Immune Function Biliary Atresia Children With Prolonged Jaundice</brief_title>
	<detailed_description>Biliary atresia patient cholestatic jaundice note increased incidence infectious complication . Previous animal model bile duct ligation acute jaundice ever demonstrate impairment humoral cellular immune function . We perform immunity study biliary atresia patient due lack comprehensive systemic immunity study pediatric cholestatic model . Systemic humoral immunity ( total serum IgG , IgA , IgM , C3 C4 ) , specific cellular immunity ( lymphocyte classification , mitogen response , cytokine level PHA stimulation test ) , non-specific cellular immunity ( absolute neutrophil count , PMN CD11b/CD18 expression level , PMN superoxide release function , PMN phagocytosis function ) test . Association serum bilirubin level , nutritional status blood biochemical value test see relation systemic immune function cholestatic jaundice .</detailed_description>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Biliary Atresia</mesh_term>
	<criteria>Biliary patient older 1yearold status post Kasai operation . Received liver transplantation , immunosuppresant , systemic immunoglobulin ( within 6 month ) obvious infectious episode ( within 2 week ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
</DOC>